Last week, Lachman hosted a virtual booth at the GRx+Biosims 2021 interactive event, where we engaged in a series of dynamic discussions around issues, trends, and challenges vital to the generic and biosimilar medicines industry.
The three-day event also featured a podcast special with AAM CEO Dan Leonard and Lachman Senior Advisor Bob Pollock. The interview-style podcast included an insightful discussion about the early challenges faced by the generics industry and how it grew from its embryonic stage to a mature industry that forms the backbone of today’s pharmaceutical business.
To access the podcast, click here.
